HCA Healthcare

presented by
Health Tech

HCA, Tenet Saw Increased EBITDA in Q1 While Nonprofit Hospitals Continued to Struggle

The nation’s two largest for-profit hospital chains — HCA and Tenet — increased their EBITDA as salary and benefit obligations became less burdensome in Q1. Unsurprisingly, the story for nonprofit hospitals is a bit different. For this class of health systems, the stress associated with labor costs is subsiding, but operating margins are having a difficult time bouncing back, according to a new Moody's report.

Health Tech

1,000+ Facilities Impacted by HCA Data Breach

HCA Healthcare recently suffered a data breach affecting 1,038 hospitals and physician clinics across 20 states. The health system said hackers stole data from an external data storage location "exclusively used to automate the formatting of email messages." It also said that the incident has not caused any disruption to HCA's daily operations or the services it provides to patients.

Health Tech

HCA CEO to Big Tech: You Can’t Disrupt Healthcare Like You’ve Disrupted Other Industries

Big Tech companies like Amazon, Google and IBM can’t disrupt healthcare with the same approach they have used to enter other industries, HCA Healthcare CEO Sam Hazen said at HLTH 2022. He argued that technology companies won't be able to infiltrate healthcare from afar. Instead, they must embed themselves into everyday healthcare interactions at hospitals in order for their products and services to be truly impactful.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.